Advisory Panel Endorses Asthmatx's Alair Device For Severe Asthma
This article was originally published in The Gray Sheet
Asthmatx's Alair bronchial thermoplasty system should be approved for severe asthma that is not adequately controlled by drugs, according to FDA's Anesthesiology and Respiratory Therapy Devices Panel
You may also be interested in...
Asthmatx is initiating a "focused launch" of its Alair bronchial thermoplasty system after receiving PMA approval April 27, according to CEO Glen French
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.